Nigeria, seven others begin African-led HIV vaccine development
Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique have begun locally-led HIV vaccine research and development.
This was disclosed at a press briefing in Abuja, on Thursday.
The conference was themed “HIV Vaccine, Innovation, Science, and Technology Acceleration in Africa Project.”
The initiative aims to harness and catalyse African scientists to contribute to an African-led effective HIV vaccine under the ‘Bringing Innovation to Clinical and Laboratory Research to End HIV in Africa through New Vaccine Technology’ (BRILLIANT) Consortium led, by the Chief Executive Officer and President of the South African Medical Research Council, Cape Town, South Africa, Prof Glenda Gray.
Thank you for watching the video, wish you health and happiness!
Subscribe to the channel at: https://goo.gl/iz6xA4
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
If you have any questions, please contact us by email: [email protected]
Sincerely thank you!
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Sign up: / @hivaidsprevention
Facebook: / hivaids2024
Twitter: / daubenh
Gmail: [email protected]